Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Vincent

Showing results (641-650 of 1,192) with videos related to

Pageof 120
Sort By:
JAMA Dermatology|December 20, 2023
Efficacy and Safety of PF-07038124 in Patients With Atopic Dermatitis and Plaque Psoriasis: A Randomized Clinical TrialLawrence F Eichenfield, Sanela Tarabar, Seth Forman, et al.
British Journal of Haematology|March 17, 2026
Preferred standard-of-care carfilzomib dosing in multiple myeloma: An international survey of haematologists/oncologistsRahul Banerjee, Sharlene Dong, Georgia McCaughan, et al.
JAMA Dermatology|October 3, 2019
Efficacy and Safety of Oral Janus Kinase 1 Inhibitor Abrocitinib for Patients With Atopic Dermatitis: A Phase 2 Randomized Clinical TrialMelinda J Gooderham, Seth B Forman, Robert Bissonnette, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|November 22, 2011
[Revisiting the dose-effect correlations in irradiated head and neck cancer using automatic segmentation tools of the dental structures, mandible and maxilla]J Thariat, L Ramus, G Odin, et al.
Clinical and Experimental Immunology|February 13, 2018
Immunoassay methods used in clinical studies for the detection of anti-drug antibodies to adalimumab and infliximabB Gorovits, D J Baltrukonis, I Bhattacharya, et al.
Mayo Clinic Proceedings|March 3, 2010
Clinical features and treatment response of light chain (AL) amyloidosis diagnosed in patients with previous diagnosis of multiple myelomaSumit Madan, Angela Dispenzieri, Martha Q Lacy, et al.
Blood|July 26, 2003
Long-term follow-up of IgM monoclonal gammopathy of undetermined significanceRobert A Kyle, Terry M Therneau, S Vincent Rajkumar, et al.
Mayo Clinic Proceedings|April 17, 2018
Fifty-Year Incidence of Waldenström Macroglobulinemia in Olmsted County, Minnesota, From 1961 Through 2010: A Population-Based Study With Complete Case Capture and Hematopathologic ReviewRobert A Kyle, Dirk R Larson, Ellen D McPhail, et al.
Cancer|February 14, 2006
Extended follow-up of a phase II trial in relapsed, refractory multiple myeloma:: final time-to-event results from the SUMMIT trialPaul G Richardson, Bart Barlogie, James Berenson, et al.
Archives of Dermatology|October 19, 2005
Successful treatment of scleromyxedema with autologous peripheral blood stem cell transplantationMartha Q Lacy, William J Hogan, Morie A Gertz, et al.
Pageof 120

Showing results (641-650 of 1,192) with videos related to

Sort By:
Pageof 120
JAMA Dermatology|December 20, 2023
Efficacy and Safety of PF-07038124 in Patients With Atopic Dermatitis and Plaque Psoriasis: A Randomized Clinical TrialLawrence F Eichenfield, Sanela Tarabar, Seth Forman, et al.
British Journal of Haematology|March 17, 2026
Preferred standard-of-care carfilzomib dosing in multiple myeloma: An international survey of haematologists/oncologistsRahul Banerjee, Sharlene Dong, Georgia McCaughan, et al.
JAMA Dermatology|October 3, 2019
Efficacy and Safety of Oral Janus Kinase 1 Inhibitor Abrocitinib for Patients With Atopic Dermatitis: A Phase 2 Randomized Clinical TrialMelinda J Gooderham, Seth B Forman, Robert Bissonnette, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|November 22, 2011
[Revisiting the dose-effect correlations in irradiated head and neck cancer using automatic segmentation tools of the dental structures, mandible and maxilla]J Thariat, L Ramus, G Odin, et al.
Clinical and Experimental Immunology|February 13, 2018
Immunoassay methods used in clinical studies for the detection of anti-drug antibodies to adalimumab and infliximabB Gorovits, D J Baltrukonis, I Bhattacharya, et al.
Mayo Clinic Proceedings|March 3, 2010
Clinical features and treatment response of light chain (AL) amyloidosis diagnosed in patients with previous diagnosis of multiple myelomaSumit Madan, Angela Dispenzieri, Martha Q Lacy, et al.
Blood|July 26, 2003
Long-term follow-up of IgM monoclonal gammopathy of undetermined significanceRobert A Kyle, Terry M Therneau, S Vincent Rajkumar, et al.
Mayo Clinic Proceedings|April 17, 2018
Fifty-Year Incidence of Waldenström Macroglobulinemia in Olmsted County, Minnesota, From 1961 Through 2010: A Population-Based Study With Complete Case Capture and Hematopathologic ReviewRobert A Kyle, Dirk R Larson, Ellen D McPhail, et al.
Cancer|February 14, 2006
Extended follow-up of a phase II trial in relapsed, refractory multiple myeloma:: final time-to-event results from the SUMMIT trialPaul G Richardson, Bart Barlogie, James Berenson, et al.
Archives of Dermatology|October 19, 2005
Successful treatment of scleromyxedema with autologous peripheral blood stem cell transplantationMartha Q Lacy, William J Hogan, Morie A Gertz, et al.
Pageof 120